1976
DOI: 10.1007/bf00758497
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological activity of adamantane derivatives. IV. Viral inhibiting activity of some adamantylamines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1978
1978
2022
2022

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 1 publication
0
3
0
Order By: Relevance
“…We observed that the 1:1 mix of CB[7]/ADA had no antiviral efficacy over the entire range (Figure B). Interestingly, ADA has an antiviral efficacy of its own; , this seems to be based on blocking a key viral protein in influenza viruses . However, when mixed at an equimolar ratio with CB[7], the antiviral efficacy of both compounds is neutralized due to the encapsulation of the ADA by CB[7], and therefore, it is unavailable to bind to and inhibit the virus.…”
Section: Resultsmentioning
confidence: 99%
“…We observed that the 1:1 mix of CB[7]/ADA had no antiviral efficacy over the entire range (Figure B). Interestingly, ADA has an antiviral efficacy of its own; , this seems to be based on blocking a key viral protein in influenza viruses . However, when mixed at an equimolar ratio with CB[7], the antiviral efficacy of both compounds is neutralized due to the encapsulation of the ADA by CB[7], and therefore, it is unavailable to bind to and inhibit the virus.…”
Section: Resultsmentioning
confidence: 99%
“…We observed that the 1:1 mix of CB [7]:ADA had no antiviral efficacy over the entire range (Figure 3B). Interestingly, ADA has antiviral efficacy of its own [46,47]; however when mixed at equimolar ratio to CB [7] the antiviral efficacy of both compounds is neutralised. We performed a similar experiment with ferrocene, another strong binder with the CB [7] cavity (>10 6 M -1 ) [48,49] and one that lacks any antiviral properties.…”
Section: Mode Of Actionmentioning
confidence: 99%
“…Much interest was shown by Russian health authorities in amantadine for prophylaxis and the population of whole towns were used in clinical trials. Currently, much of the work on analogues of amantadine is taking place in Russia with Danilenko and his colleagues in Kiev publishing a series of papers on synthesis and biological activity [118][119][120][121], and groups at the Influenza research centres in Moscow, Leningrad and Riga reporting on synthesis, biological studies and clinical studies [122][123][124]. These groups have a great interest in a-methyl-I-adamantanemethylamine hydrochloride (XI, rimantadine) and its analogues.…”
Section: "Cimentioning
confidence: 99%